CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 302 enrolled
Drug / intervention
ACUVUE Oasys 1-Day +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04968925
NCT04968925N/ACompleted
CompareCT.gov

Evaluation of Comfort for Two Marketed Daily Disposable Contact Lenses

Johnson & Johnson Vision Care, Inc.·interventional·Posted Jul 20, 2021·Updated Dec 22, 2022

In Brief

A clinical study evaluating ACUVUE Oasys 1-Day and Precision 1 for Visual Acuity. Completed, enrolled 302 participants across 10 sites.

Detailed Summary

This study is a 2-phase adaptive approach utilizing a 2×2 crossover design. The study lenses will be worn in a bilateral fashion for a period of approximately 1-week each.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJul 20, 2021
Enrollment StartJul 12, 2021
Primary CompletionOct 25, 2021
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 5.0 years ago

Interventions

ACUVUE Oasys 1-Daydevice

TEST

Precision 1device

CONTROL